期刊文献+

Impact of Solid / Vapour Equilibria on Conditions of Crystallization of Pharmaceutical Compounds

Impact of Solid / Vapour Equilibria on Conditions of Crystallization of Pharmaceutical Compounds
下载PDF
导出
摘要 The influence of solvent (in its gaseous state) on the stability of crystallized organic compounds was investigated. Through two examples of studies on the solid/vapour equilibria made in our lab, several behaviors were highlighted: (i) a new hydrated phase (thermodynamically stable) of an active pharmaceutical ingredient (API) was detected after the recrystallization starting from a deliquescent state, (ii) a spontaneous resolution of a hydrated racemic compound towards an anhydrous conglomerate can occur during the desolvation under the precise conditions of temperature and humidity. This study illustrates that knowledge about solid/vapour equilibrium is a crucial step during the complete characterization of solid organic compounds. The influence of solvent (in its gaseous state) on the stability of crystallized organic compounds was investigated. Through two examples of studies on the solid/vapour equilibria made in our lab, several behaviors were highlighted: (i) a new hydrated phase (thermodynamically stable) of an active pharmaceutical ingredient (API) was detected after the recrystallization starting from a deliquescent state, (ii) a spontaneous resolution of a hydrated racemic compound towards an anhydrous conglomerate can occur during the desolvation under the precise conditions of temperature and humidity. This study illustrates that knowledge about solid/vapour equilibrium is a crucial step during the complete characterization of solid organic compounds.
出处 《Transactions of Tianjin University》 EI CAS 2013年第1期53-57,共5页 天津大学学报(英文版)
关键词 solid/vapour equilibria hydrates deliquescence pharmaceutical solids dynamic vapour sorption 有机化合物 结晶条件 药物成分 气平衡 外消旋化合物 气体状态 蒸汽平衡 水合过程
  • 相关文献

参考文献17

  • 1Authelin J R. Thermodynamics of non-stoichiometric pharmaceutical hydrates[J]. International Journal of Pharmaceuties, 2005, 303 (1/2) :37-53.
  • 2Henck J O, Griesser U J, Burger A. Polymorphism of drug substances: An economic challenge[J]. Pharm Ind, 1997, 59 (2) : 165-169 (in German).
  • 3Khanhari R, Chen L, Grant D J W. Physical characteriza- tion of nedocromil sodium hydrates [J]. J Pharm Sci, 1998, 87 (9) : 1052-1061.
  • 4Petit S, Coquerel G. Mechanism of several solid-solid transformations between dihydrated and anhydrous copper (Ⅱ) 8-hydroxyquinolinates. Proposition for a unified model for the dehydration of molecular crystals [J]. Chem Mater, 1996, 8 (9): 2247-2258.
  • 5Chan M N, Kreidenweis S M, Chan C K. Measurements of hygroscopic and deliquescence properties of organic com- pounds of different solubilities in water and their relation- ship with cloud condensation nuclei activities[J]. Env Sci Tech, 2008, 42 (10) : 3602-3608.
  • 6Coquerel G, Sanselme M, Lafontaine A. Method of Measuring Scattering of X-rays, Its Applications and Implementation Device: WO, 136921. A1 [P]. 2011-04- 06 (in French).
  • 7Descamps G. Purification by Crystallization of a New Or- ganic Phosphored Active Pharmaceutical Ingredient [D]. University of Rouen, Rouen, 2009 (in French).
  • 8Amharar Y, Petit S, Sanselme Met al. Crystal structures, dehydration mechanism and chiral discrimination in the solid state of hydantoin derivatives [J]. Cryst Growth Des, 2011, 11 (6): 2453-2462.
  • 9Descamps G, Amharar Y, Cartigny Y et al. Novel Polymor- phic Form of CHDMAPP, Method of Preparation Thereof, and Pharmaceutical Composition Comprising Same: WO, 029062.A1 [P]. 2010-03-18.
  • 10Newman W, Reutzel-Edens S M, Zografi G. Characterization of the "hygroscopic" properties of an active pharmaceutical ingredient [J]. J Pharm Sci, 2008, 97 (3) : 1047-1059.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部